To evaluate the inhibitory effects of ABL1 inhibitors on ovarian cancer cells with elevated SYCP2 expression, we measured expression of SYCP2 in several ovarian cancer cell lines (Fig. 1E). The gene discussed is ABL1; the disease is ovarian carcinoma.